DUSP4 and fatty liver disease: Consistent with resistance to hepatic steatosis, Mkp-2−/− mice exhibited a marked reduction in liver weight (Figure 5B) and hepatic triglycerides (TGs) (Figure 5C) compared with Mkp-2+/+ mice.